Company intelligence / Profile preview

Confo Therapeutics

Ownership: Private
Employees: ~75
Development stage: Phase 1

Overview

Confo Therapeutics has advanced its proprietary pipeline into the clinic, focusing on novel small molecule and antibody-based drugs targeting GPCRs for metabolic and endocrine diseases. The company’s technology enables access to previously undruggable targets. It has demonstrated proof-of-concept in vivo studies for its lead programs, secured major pharma partnerships, and raised significant funding to support ongoing clinical trials.

Therapeutic areas: EndocrinologyNeurologyMetabolic Disorders
Modalities: Small moleculesAntibody-based therapeutics (including single-domain antibodies/ConfoBodies)
Industry: Biotech

Drug pipeline

6 assets

pN162

Preclinical

5 more assets in the full pipeline.

Request access →

Partnerships

Roche (drug discovery collaboration/licensing for neurological/developmental disorder target)Lundbeck (collaboration on CNS-related GPCR drug discovery)Regeneron Pharmaceuticals (antibody-based therapies using platform technology)

Beyond the preview

Go deeper on Confo Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Confo Therapeutics.

Explore the full profile